{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:30:08Z","timestamp":1758040208419,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006221","name":"Cordis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.amjcard.2024.01.027","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T21:11:10Z","timestamp":1708117870000},"page":"43-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The End of a Controversy: The Rise, Fall, and Redemption of Paclitaxel-Coated Devices"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3861-3163","authenticated-orcid":false,"given":"Eric A.","family":"Secemsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-2839","authenticated-orcid":false,"given":"William","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2024.01.027_bib0001","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jvs.2019.01.080","article-title":"Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease","volume":"70","author":"Caradu","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011245","article-title":"Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK","volume":"6","author":"Katsanos","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0003","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jvs.2019.05.034","article-title":"Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries","volume":"71","author":"Mohapatra","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/1358863X211043567","article-title":"Trends in drug-coated device use for peripheral artery disease: insights from the Vascular Quality Initiative (VQI)","volume":"27","author":"Pichert","year":"2022","journal-title":"Vasc Med"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0005","first-page":"124","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","volume":"92","author":"Feldman","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0006","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jcin.2018.01.233","article-title":"Public health impact of the Centers for Medicare and Medicaid Services decision on pass-through add-on payments for drug-coated balloons: a call to action","volume":"11","author":"Shishehbor","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0008","unstructured":"McKeown LA. Two trials halted in wake of study linking paclitaxel-coated devices to deaths in PAD. TCTMD. Available at:https:\/\/www.tctmd.com\/news\/two-trials-halted-wake-study-linking-paclitaxel-coated-devices-deaths-pad. Accessed on April 3, 2019."},{"key":"10.1016\/j.amjcard.2024.01.027_bib0009","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/CIRCULATIONAHA.119.041099","article-title":"Paclitaxel-coated balloons and eluting stents: is there a mortality risk in patients with peripheral artery disease?","volume":"140","author":"Beckman","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0010","unstructured":"Treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents potentially associated with increased mortality - letter to health care providers. United States Food and Drug Administration. Available at:https:\/\/www.fda.gov\/MedicalDevices\/Safety\/LetterstoHealthCareProviders\/ucm633614.htm. Accessed on March 26, 2019."},{"key":"10.1016\/j.amjcard.2024.01.027_bib0011","unstructured":"Paclitaxel-coated drug-coated balloon (DCB) and drug-eluting stent (DES) late mortality panel, circulatory system devices panel meeting: general issues meeting. United States Food and Drug Administration. Available at: https:\/\/www.fda.gov\/media\/127698\/download. Accessed on March 21, 2020."},{"key":"10.1016\/j.amjcard.2024.01.027_bib0012","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","article-title":"Mortality and paclitaxel-coated devices: an individual patient data meta-analysis","volume":"141","author":"Rocha-Singh","year":"2020","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.amjcard.2024.01.027_bib0013","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0014","unstructured":"Framework for FDA's real-world evidence program. United States Food and Drug Administration. Available at: https:\/\/www.fda.gov\/media\/120060\/download. Accessed on September 26, 2023."},{"key":"10.1016\/j.amjcard.2024.01.027_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007040","article-title":"SAFE-PAD Investigators. Rationale and design of the SAFE-PAD study","volume":"14","author":"Secemsky","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012074","article-title":"Update from the longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among Medicare beneficiaries: the SAFE-PAD study","volume":"15","author":"Secemsky","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0017","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamainternmed.2021.2738","article-title":"Longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among Medicare beneficiaries: the SAFE-PAD study","volume":"181","author":"Secemsky","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0018","unstructured":"UPDATE: paclitaxel-coated devices to treat peripheral arterial disease unlikely to increase risk of mortality - letter to health care providers. United States Food and Drug Administration. Available at:https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/update-paclitaxel-coated-devices-treat-peripheral-arterial-disease-unlikely-increase-risk-mortality. Accessed on September 26, 2023."},{"key":"10.1016\/j.amjcard.2024.01.027_bib0019","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0140-6736(23)02189-X","article-title":"Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis","volume":"402","author":"Parikh","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006589","article-title":"Comparability of event adjudication versus administrative billing claims for outcome ascertainment in the DAPT study: findings from the EXTEND-DAPT study","volume":"14","author":"Faridi","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0021","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ejvs.2022.01.009","article-title":"Accuracy of administrative claims codes for identifying devices used in endovascular femoropopliteal artery revascularisation: a retrospective observational study at Two Tertiary Centres in The United States","volume":"63","author":"Raja","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.amjcard.2024.01.027_bib0022","doi-asserted-by":"crossref","first-page":"e955","DOI":"10.4244\/EIJ-D-23-00432","article-title":"Outcomes of atherectomy in patients undergoing lower extremity revascularisation","volume":"19","author":"Albaghdadi","year":"2023","journal-title":"EuroIntervention"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:53:07Z","timestamp":1757573587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914924000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":22,"alternative-id":["S0002914924000948"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.01.027","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The End of a Controversy: The Rise, Fall, and Redemption of Paclitaxel-Coated Devices","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}